Re: Cardiovascular side effects of diethylstilbestrol, cyproterone acetate, medroxyprogesterone acetate and estramustine phosphate used for the treatment of advanced prostatic cancer: results from European Organization for Research on Treatment of Cancer Trials 30761 and 30762

J Urol. 1988 Dec;140(6):1557. doi: 10.1016/s0022-5347(17)42118-5.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Clinical Trials as Topic
  • Cyproterone / adverse effects
  • Cyproterone / analogs & derivatives
  • Cyproterone Acetate
  • Diethylstilbestrol / adverse effects
  • Estramustine / adverse effects
  • Heart / drug effects*
  • Humans
  • Male
  • Medroxyprogesterone / adverse effects
  • Medroxyprogesterone / analogs & derivatives
  • Medroxyprogesterone Acetate
  • Prostatic Neoplasms / drug therapy*

Substances

  • Estramustine
  • Cyproterone Acetate
  • Diethylstilbestrol
  • Medroxyprogesterone Acetate
  • Cyproterone
  • Medroxyprogesterone